Kprx stock price.

Get the latest Kiora Pharmaceuticals, Inc. (KPRX) stock news and headlines to help you in your trading and investing decisions.

Kprx stock price. Things To Know About Kprx stock price.

The average Rigel Pharmaceuticals stock price for the last 52 weeks is 1.27. For more information on how our historical price data is adjusted see the Stock ...The problem with KPRX stock is that its shares have remained below the $1 minimum bid price for 30 consecutive business days. According to this filing, Kiora Pharmaceuticals now has 180 days to ...The reverse stock split caused the price of KPRX stock to jump from its prior value of 18 cents per share when markets closed on Monday. This saw the stock opening on Tuesday at a price of $6.18 ...Kiora Pharmaceuticals is a clinical-stage specialty pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases. …

Kiora Pharmaceuticals stock was originally listed at a price of $3,600.00 in Feb 13, 2015. If you had invested in Kiora Pharmaceuticals stock at $3,600.00, your return over the last …AAO Late-Breaking: Kiora's Small Molecule Photoswitch Demonstrates Meaningful Vision Improvements in Blind Patients with Retinitis Pigmentosa. Find the latest Kiora Pharmaceuticals, Inc. (KPRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Mar 1, 2022 ... One thing to consider is that the analyst outlook remains optimistic with the current pipeline. Maxim Group initiated coverage on KPRX stock ...Ampio Pharmaceuticals' stock was trading at $4.5040 at the beginning of the year. Since then, AMPE shares have decreased by 56.5% and is now trading at $1.9599. View the best growth stocks for 2023 here.

Tonix Pharmaceuticals' stock was trading at $2.4363 on January 1st, 2023. Since then, TNXP shares have decreased by 80.1% and is now trading at $0.4855. View the best growth stocks for 2023 here.Kiora Pharmaceuticals Inc (KPRX) Message Board - Company Name: Kiora Pharmaceuticals Inc, Stock Symbol: KPRX, Industry: Biotechs - Total Posts: 45 - Last Post: 08/31/2023 03:21:18 PM - company/specific stock boardAccording to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.Dec 30, 2022 · Kiora Pharmaceuticals Inc (KPRX) stock is higher by 20.84% while the S&P 500 is lower by -1.1% as of 2:38 PM on Friday, Dec 30. KPRX is higher by $0.59 from the previous closing price of $2.83 on volume of 1,108,749 shares. Over the past year the S&P 500 is lower by -20.58% while KPRX is lower by -90.28%.

The Catalyst Pharmaceuticals stock price gained 2.70% on the last trading day (Friday, 1st Dec 2023), rising from $14.43 to $14.82. During the last trading day the stock fluctuated 3.48% from a day low at $14.35 to a day high of $14.85. The price has risen in 8 of the last 10 days and is up by 10.76% over the past 2 weeks.

Kiora Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target KPRX. High $ 33.00: Median $ 3.50: Low $ 2.00: Average $ 12.83: Current ...

A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CVNA shares currently have a short interest ratio of 4.0. Learn More on Carvana's short interest ratio.On Friday, Kiora Pharmaceuticals Inc (KPRX:NAQ) closed at 0.6335, 37.06% above the 52 week low of 0.4622 set on Sep 05, 2023. Data delayed at least 15 minutes, as of Nov 10 2023 20:59 GMT. Latest Kiora Pharmaceuticals Inc (KPRX:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.Dec 30, 2022 · Kiora Pharmaceuticals Inc (KPRX) stock is higher by 20.84% while the S&P 500 is lower by -1.1% as of 2:38 PM on Friday, Dec 30. KPRX is higher by $0.59 from the previous closing price of $2.83 on volume of 1,108,749 shares. Over the past year the S&P 500 is lower by -20.58% while KPRX is lower by -90.28%. Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.ROKU Stock 12 Months Forecast. $85.05. (2.67% Upside) Based on 24 Wall Street analysts offering 12 month price targets for Roku in the last 3 months. The average price target is $85.05 with a high forecast of $115.00 and a low forecast of $55.00. The average price target represents a 2.67% change from the last price of $82.84.

Ampio Pharmaceuticals' stock was trading at $4.5040 at the beginning of the year. Since then, AMPE shares have decreased by 56.5% and is now trading at $1.9599. View the best growth stocks for 2023 here.Get historical data for the NYSE U.S. 100 Index (^NY) on Yahoo Finance. View and download daily, weekly or monthly data to help your investment decisions.Find the latest Summit Therapeutics Inc. (SMMT) stock quote, history, news and other vital information to help you with your stock trading and investing.Kiora Pharmaceuticals Inc (KPRX) stock is trading at $5.25 as of 11:26 AM on Tuesday, Feb 14, a loss of -$0.93, or -15.05% from the previous closing price of $6.18. The stock has traded between $5.18 and $6.11 so far today. Volume today is below average. So far 307,487 shares have traded compared to average volume of 3,022,793 shares. Click ...Warrants to purchase one share of Common Stock at an exercise price of $1 AMPX WS TXN3-8 Y Tape A ... Common Stock KPRX TXN14-5 N Tape C. Karyopharm Therapeutics ...Kiora Pharmaceuticals, Inc. Common Stock (KPRX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

Find the latest Kiora Pharmaceuticals, Inc. (KPRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Kiora Pharmaceuticals stock was originally listed at a price of $3,600.00 in Feb 13, 2015. If you had invested in Kiora Pharmaceuticals stock at $3,600.00, your return over the last …With Kiora Pharmaceuticals stock trading at $0.53 per share, the total value of Kiora Pharmaceuticals stock (market capitalization) is $4.07M. Kiora Pharmaceuticals stock was originally listed at a price of $3,600.00 in Feb 13, 2015.Jul-26-22 04:38PM. Kiora Pharmaceuticals Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option. (Newsfile) Jul-22-22 08:30AM. Kiora Pharmaceuticals Announces Pricing of $5.2 Million Underwritten Public Offering. (Newsfile) -39.76%.Nov 30, 2023 · Complete Kiora Pharmaceuticals Inc. stock information by Barron's. View real-time KPRX stock price and news, along with industry-best analysis. 1.09%. $59.66M. AMC | Complete AMC Entertainment Holdings Inc. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The 3 analysts offering 1 year price forecasts for KPRX have a max estimate of — and a min estimate of —. Analyst rating Based on 3 analysts giving stock ratings to KPRX in the past 3 months.R$476.67B. Suncor Energy Inc. -0.47%. $57.67B. XOM | Complete Exxon Mobil Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Adani Ent. share price was Rs 2,362.70 as on 01 Dec, 2023, 04:07 PM IST. Adani Ent. share price was up by 0.17% based on previous share price of Rs 2,396.6. Adani Ent. share price trend: Last 1 Month: Adani Ent. share price moved up by 6.56%. Last 3 Months: Adani Ent. share price moved down by 3.57%.

View the latest Johnson & Johnson (JNJ) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Kiora Pharmaceuticals (KPRX) Stock Price, Quote, News & Analysis - TipRanks.com. Analyst ForecastsNews & Insights. TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. Kiora Pharmaceuticals (KPRX) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst ...

View Cassava Sciences (SAVA) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo ... (KPRX) and Bluebird Bio (BLUE).Virpax Pharmaceuticals (VRPX) said it signed a cooperative research and development agreement ((CRADA)) with the U.SFind the latest SoundHound AI, Inc. (SOUN) stock quote, history, news and other vital information to help you with your stock trading and investing.Real time Kiora Pharmaceuticals (EYEG) stock price quote, stock graph, news & analysis ... Price VS S&P. KPRX. Key Data Points. Current Price. The most recent ...Kiora Pharmaceuticals is a clinical-stage specialty pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases. …Jul-26-22 04:38PM. Kiora Pharmaceuticals Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option. (Newsfile) Jul-22-22 08:30AM. Kiora Pharmaceuticals Announces Pricing of $5.2 Million Underwritten Public Offering. (Newsfile) -39.76%. Mar 1, 2022 ... One thing to consider is that the analyst outlook remains optimistic with the current pipeline. Maxim Group initiated coverage on KPRX stock ...Nov 14, 2023 ... KPRX stock had a mixed performance on November 14, 2023. The stock opened at $0.62, slightly lower than the previous day's close. Throughout the ...What is KPRX stock price target? The target price for KPRX stock is $12.83 based on the average of what a group of analyst think KPRX stock could be worth at a future date. This is not a prediction by Public.com

NVIDIA Corporation Common Stock. $452.12 -0.61 -0.13%. Kiora Pharmaceuticals, Inc. Common Stock (KPRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US ...If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Nov 23, 2023 · The public float for KPRX is 6.97M, and at present, short sellers hold a 4.63% of that float. The average trading volume of KPRX on November 23, 2023 was 304.45K shares. KPRX) stock’s latest price update. The stock of Kiora Pharmaceuticals Inc (NASDAQ: KPRX) has decreased by -5.61 when compared to last closing price of 0.56.Despite this, the ... View the latest Kiora Pharmaceuticals Inc. (KPRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Instagram:https://instagram. biggest gain stocks todayoleada bagbest free tax software for self employed10 cent stocks KPRX -4.69%. 39. See KPRX Report. Kiora Pharmaceuticals Inc ( KPRX) is down Friday morning, with the stock losing -36.53% in pre-market trading to 1.06. KPRX's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 66 out ... energy penny stockmercedes maybach gls Ampio Pharmaceuticals' stock was trading at $4.5040 at the beginning of the year. Since then, AMPE shares have decreased by 56.5% and is now trading at $1.9599. View the best growth stocks for 2023 here.Find the latest DermTech, Inc. (DMTK) stock quote, history, news and other vital information to help you with your stock trading and investing. geely auto The latest price target for Palisade Bio ( NASDAQ: PALI) was reported by Ladenburg Thalmann on Tuesday, May 16, 2023. The analyst firm set a price target for 16.00 expecting PALI to rise to within ...KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.